Department of Neurology, Mayo Clinic, Rochester, MN, USA.
Neurology. 2012 Mar 6;78(10):702-8. doi: 10.1212/WNL.0b013e3182494d66. Epub 2012 Feb 22.
Autonomic deficits in chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) have not been adequately quantitated. The Composite Autonomic Severity Score (CASS) is a validated instrument for laboratory quantitation of autonomic failure derived from standard autonomic reflex tests. We characterized dysautonomia in CIDP using CASS.
Autonomic function was retrospectively analyzed in 47 patients meeting CIDP criteria. CASS ranges from 0 (normal) to 10 (pandysautonomia), reflecting summation of sudomotor (0-3), cardiovagal (0-3), and adrenergic (0-4) subscores. Severity of neurologic deficits was measured with Neuropathy Impairment Score (NIS). Degree of small fiber involvement was assessed with quantitative sensation testing. Thermoregulatory sweat test (TST) was available in 8 patients.
Patients (25 men) were middle-aged (45.0 ± 14.9 years) with longstanding CIDP (3.5 ± 4.3 years) of moderate severity (NIS, 46.5 ± 32.7). Autonomic symptoms were uncommon, mainly gastrointestinal (9/47; 19%) and genitourinary (8/47; 17%). Autonomic deficits (CASS ≥1) were frequent (22/47; 47%) but very mild (CASS, 0.8 ± 0.9; CASS ≤3, all cases). Deficits were predominantly sudomotor (16/47; 34%) and cardiovagal (10/47; 21%) with relative adrenergic sparing (4/47; 9%). TST was abnormal in 5 of 8 patients (anhidrosis range, 2%-59%). Sudomotor impairment was predominantly distal and postganglionic. Somatic deficits (disease duration, severity, small fiber deficits) did not predict presence of autonomic deficits.
Our data characterize the autonomic involvement in classic CIDP as mild, cholinergic, and predominantly sudomotor mainly as a result of lesions at the distal postganglionic axon. Extensive or severe autonomic involvement (CASS ≥4) in suspected CIDP should raise concern for an alternative diagnosis.
慢性炎症性脱髓鞘性多发性神经病(CIDP)中的自主神经缺陷尚未得到充分定量。综合自主严重程度评分(CASS)是一种经过验证的仪器,可用于从标准自主反射测试中定量评估自主衰竭。我们使用 CASS 来描述 CIDP 中的自主神经功能障碍。
回顾性分析了 47 例符合 CIDP 标准的患者的自主神经功能。CASS 的范围为 0(正常)至 10(全自主神经功能障碍),反映了出汗(0-3)、心脏迷走神经(0-3)和肾上腺素能(0-4)亚评分的总和。神经病学缺损的严重程度用神经病变损伤评分(NIS)测量。小纤维受累程度用定量感觉测试评估。热调节出汗试验(TST)可用于 8 例患者。
患者(25 名男性)年龄为中年(45.0 ± 14.9 岁),患有 CIDP 病史较长(3.5 ± 4.3 年),病情中等严重程度(NIS,46.5 ± 32.7)。自主症状不常见,主要为胃肠道(9/47;19%)和泌尿生殖系统(8/47;17%)。自主神经缺陷(CASS≥1)很常见(22/47;47%),但非常轻微(CASS,0.8 ± 0.9;CASS≤3,所有病例)。缺陷主要是出汗(16/47;34%)和心脏迷走神经(10/47;21%),肾上腺素能相对保留(4/47;9%)。8 例患者中有 5 例 TST 异常(无汗范围,2%-59%)。出汗功能障碍主要是远端和节后的。躯体缺陷(疾病持续时间、严重程度、小纤维缺陷)不能预测自主神经缺陷的存在。
我们的数据将经典 CIDP 中的自主神经受累特征描述为轻度、胆碱能、主要是出汗,主要是由于节后远段轴突的病变所致。疑似 CIDP 中广泛或严重的自主神经受累(CASS≥4)应引起对其他诊断的关注。